You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.


( awk-TREE-oh-tide )
ODB - General Benefit
  • octreotide
Other Name(s): Sandostatin® (multiple brands available); Sandostatin® LAR™ (Novartis)
Appearance: Long-acting- LAR kit; Short-acting- colourless solution available in ampoules or in multi-dose vials

Patient Info Sheet

Feb 2012

What it is used for

• For controlling symptoms such as severe diarrhea or flushing. These symptoms may occur with certain cancers of the gastrointestinal tract.

You might also be interested in